BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Lei JY, Wang WT, Yan LN. Up-to-seven criteria for hepatocellular carcinoma liver transplantation: A single center analysis. World J Gastroenterol 2013; 19(36): 6077-6083 [PMID: 24106409 DOI: 10.3748/wjg.v19.i36.6077]
URL: https://www.wjgnet.com/1948-5182/full/v19/i36/6077.htm
Number Citing Articles
1
Arno Kornberg, Ulrike Witt, Martina Schernhammer, Jennifer Kornberg, Gueralp O. Ceyhan, Katharina Mueller, Helmut Friess, Katharina Thrum. Combining 18F-FDG positron emission tomography with Up-to-seven criteria for selecting suitable liver transplant patients with advanced hepatocellular carcinomaScientific Reports 2017; 7(1) doi: 10.1038/s41598-017-14430-9
2
Bianca Magro, Domenico Pinelli, Massimo De Giorgio, Maria Grazia Lucà, Arianna Ghirardi, Alessandra Carrobio, Giuseppe Baronio, Luca Del Prete, Franck Nounamo, Andrea Gianatti, Michele Colledan, Stefano Fagiuoli. Pre-Transplant Alpha-Fetoprotein > 25.5 and Its Dynamic on Waitlist Are Predictors of HCC Recurrence after Liver Transplantation for Patients Meeting Milan CriteriaCancers 2021; 13(23): 5976 doi: 10.3390/cancers13235976
3
John C McVey, Kazunari Sasaki, Daniel J Firl. Risk assessment criteria in liver transplantation for hepatocellular carcinoma: proposal to improve transplant oncologyHepatic Oncology 2020; 7(3) doi: 10.2217/hep-2020-0003
4
Volkan Ince, Tevfik Tolga Sahin, Sami Akbulut, Sezai Yilmaz. Liver transplantation for hepatocellular carcinoma: Historical evolution of transplantation criteriaWorld Journal of Clinical Cases 2022; 10(29): 10413-10427 doi: 10.12998/wjcc.v10.i29.10413
5
Ashok Thorat, Long-Bin Jeng, Horng-Ren Yang, Chun-Chieh Yeh, Shih-Chao Hsu, Te-Hung Chen, Kin-Shing Poon. Assessing the role of everolimus in reducing hepatocellular carcinoma recurrence after living donor liver transplantation for patients within the UCSF criteria: re-inventing the role of mammalian target of rapamycin inhibitorsAnnals of Hepato-Biliary-Pancreatic Surgery 2017; 21(4): 205 doi: 10.14701/ahbps.2017.21.4.205
6
Guergana Panayotova, Keri E Lunsford, Nyan L Latt, Flavio Paterno, James V Guarrera, Nikolaos Pyrsopoulos. Expanding indications for liver transplantation in the era of liver transplant oncologyWorld Journal of Gastrointestinal Surgery 2021; 13(5): 392-405 doi: 10.4240/wjgs.v13.i5.392
7
Tamar Thurm, Oren Shibolet. Hepatocellular Carcinoma2016; : 409 doi: 10.1007/978-3-319-34214-6_27
8
L. Jiang, J. Y. Lei, W. T. Wang, L. N. Yan, B. Li, T. F. Wen, M. Q. Xu, J. Y. Yang, Y. G. Wei. Immediate Radical Therapy or Conservative Treatments When Meeting the Milan Criteria for Advanced HCC Patients After Successful TACEJournal of Gastrointestinal Surgery 2014; 18(6): 1125 doi: 10.1007/s11605-014-2508-2
9
Duilio Pagano, Simone Khouzam, Bianca Magro, Marco Barbara, Davide Cintorino, Fabrizio di Francesco, Sergio Li Petri, Pasquale Bonsignore, Sergio Calamia, Giacomo Deiro, Calogero Cammà, Marco Canzonieri, Salvatore Gruttadauria. How important is the role of iterative liver direct surgery in patients with hepatocellular carcinoma for a transplant center located in an area with a low rate of deceased donation?Frontiers in Oncology 2022; 12 doi: 10.3389/fonc.2022.929607
10
Hanaa Hibishy Gaballah, Soha Said Zakaria, Saber Abdelrahman Ismail. Activity and Expression Pattern of NF-κB/P65 in Peripheral Blood from Hepatocellular Carcinoma Patients - Link to Hypoxia Inducible Factor -1αAsian Pacific Journal of Cancer Prevention 2014; 15(16): 6911 doi: 10.7314/APJCP.2014.15.16.6911
11
Marta Guerrero-Misas, Manuel Rodríguez-Perálvarez, Manuel De la Mata. Strategies to improve outcome of patients with hepatocellular carcinoma receiving a liver transplantationWorld Journal of Hepatology 2015; 7(4): 649-661 doi: 10.4254/wjh.v7.i4.649
12
Mehmet Haluk Morgul, Philipp Felgendreff, Andreas Kienlein, Ulrich Gauger, Katrin Semmling, Hans-Michael Hau, Hans-Michael Tautenhahn, Michael Bartels. Milan criteria in the MELD era—is it justifiable to extend the limits for orthotopic liver transplantation?World Journal of Surgical Oncology 2020; 18(1) doi: 10.1186/s12957-020-01932-6
13
S. E. Voskanyan, E. V. Naidenov, A. I. Artemiev, I. Yu. Kolyshev, D. A. Zabezhinsky, K. K. Gubarev, V. S. Rudakov, M. V. Shabalin, A. I. Sushkov, M. V. Popov, D. S. Svetlakova, A. P. Maltseva, M. Muktarzhan, Z. Sadykhov, E. V. Vidmer. Long-term results of liver transplantation for hepatocellular cancerAnnaly khirurgicheskoy gepatologii = Annals of HPB Surgery 2021; 26(2): 68 doi: 10.16931/10.16931/1995-5464.2021-2-68-82
14
F.J. León Díaz, J.A. Pérez Daga, B. Sánchez Pérez, J.L. Fernández Aguilar, C. Montiel Casado, J.M. Aranda Narváez, M.A. Suárez Muñoz, L. Romacho López, J. Santoyo Villalba, J. Santoyo Santoyo. Up-to-7 Criteria for Hepatocellular Carcinoma Liver Transplantation: A Retrospective Analysis of ExperiencesTransplantation Proceedings 2016; 48(9): 2969 doi: 10.1016/j.transproceed.2016.08.035
15
Kyung-Suk Suh, Hae Won Lee. Liver transplantation for advanced hepatocellular carcinoma: how far can we go?Hepatic Oncology 2015; 2(1): 19 doi: 10.2217/hep.14.34
16
Guilherme Moura Cunha, Mojgan Hosseini, Alessandro Furlan, Kathryn J. Fowler. Hepatocellular Carcinoma Staging: Differences Between Radiologic and Pathologic Systems and Relevance to Patient Selection and Outcomes in Liver TransplantationAmerican Journal of Roentgenology 2022; 218(1): 77 doi: 10.2214/AJR.21.26436
17
Marie Decraecker, Caroline Toulouse, Jean-Frédéric Blanc. Is There Still a Place for Tyrosine Kinase Inhibitors for the Treatment of Hepatocellular Carcinoma at the Time of Immunotherapies? A Focus on LenvatinibCancers 2021; 13(24): 6310 doi: 10.3390/cancers13246310
18
Haniee Chung, William C Chapman. Liver transplantation for hepatocellular carcinoma: how far have we come and what is the future?Hepatic Oncology 2014; 1(3): 309 doi: 10.2217/hep.14.8
19
Jiliang Feng, Ruidong Zhu, Dezhao Feng, Lu Yu, Dawei Zhao, Jushan Wu, Chunwang Yuan, Junmei Chen, Yan Zhang, Xiu Zheng. Prediction of Early Recurrence of Solitary Hepatocellular Carcinoma after Orthotopic Liver TransplantationScientific Reports 2019; 9(1) doi: 10.1038/s41598-019-52427-8
20
Stefania Brozzetti, Simone Bini, Chiara D’Alterio, Chiara De Lucia, Leonardo Luca Chiarella, Katia Fazzi, Michele Di Martino. Liver Disease and Surgery [Working Title]2019;  doi: 10.5772/intechopen.86638
21
Alexander Clevewood Ng. Stick to Milan: Infeasibility of the Brazil-Milan Criteria in recommending patients with hepatocellular carcinoma for liver transplantationAnnals of Hepatology 2021; 25: 100537 doi: 10.1016/j.aohep.2021.100537
22
Jiliang Feng, Junmei Chen, Ruidong Zhu, Lu Yu, Yan Zhang, Dezhao Feng, Heli Kong, Chenzhao Song, Hui Xia, Jushan Wu, Dawei Zhao. Prediction of early recurrence of hepatocellular carcinoma within the Milan criteria after radical resectionOncotarget 2017; 8(38): 63299 doi: 10.18632/oncotarget.18799
23
Daniel P. Milgrom, Mary A. Maluccio, Leonidas G. Koniaris. Management of Hepatocellular Carcinoma (HCC)Current Surgery Reports 2016; 4(6) doi: 10.1007/s40137-016-0143-4
24
T. K. Chattopadhyay. GI Surgery AnnualGI Surgery Annual 2018; 24: 177 doi: 10.1007/978-981-13-0161-2_8
25
Chuan Hao Gui, Samantha Baey, Reuban Toby D'cruz, Vishal G. Shelat. Trans-arterial chemoembolization + radiofrequency ablation versus surgical resection in hepatocellular carcinoma – A meta-analysisEuropean Journal of Surgical Oncology 2020; 46(5): 763 doi: 10.1016/j.ejso.2020.01.004
26
Hari Krishna Kanduri, Aili xire, Sai Charan Goud Kurelli, Sanawar Abbas, Jian Wang, Wenya Liu. Role of imaging in pre-hepatic transplantation evaluationRadiology of Infectious Diseases 2019; 6(4): 133 doi: 10.1016/j.jrid.2020.02.004
27
Li-ying Wang, Shu-sen Zheng. Advances in predicting the prognosis of hepatocellular carcinoma recipients after liver transplantationJournal of Zhejiang University-SCIENCE B 2018; 19(7): 497 doi: 10.1631/jzus.B1700156
28
Dimitrios Papaconstantinou, D. Brock Hewitt, Zachary J. Brown, Dimitrios Schizas, Diamantis I. Tsilimigras, Timothy M. Pawlik. Patient stratification in hepatocellular carcinoma: impact on choice of therapyExpert Review of Anticancer Therapy 2022; 22(3): 297 doi: 10.1080/14737140.2022.2041415
29
Yang Hai, Esika Savsani, Weelic Chong, John Eisenbrey, Andrej Lyshchik. Meta-analysis and systematic review of contrast-enhanced ultrasound in evaluating the treatment response after locoregional therapy of hepatocellular carcinomaAbdominal Radiology 2021; 46(11): 5162 doi: 10.1007/s00261-021-03248-9